#28 - Denis Noble - Why The Last 80 Years of Biology Was Wrong & What Does it Mean For Us?
The Innovation Civilization PodcastShow Notes
We're joined by Dr. Denis Noble, Professor Emeritus of Cardiovascular Physiology at the University of Oxford, and the father of 'systems biology'. He is known for his groundbreaking creation of the first mathematical model of the heart's electrical activity in the 1960s which radically transformed our understanding of the heart.
Dr. Noble’s contributions have revolutionized our understanding of cardiac function and the broader field of biology. His work continues to challenge long-standing biological concepts, including gene-centric views like Neo-Darwinism.
In this episode, Dr. Noble discusses his critiques of fundamental biological theories that have shaped science for over 80 years, such as the gene self-replication model and the Weissmann barrier. He advocates for a more holistic, systems-based approach to biology, where genes, cells, and their environments interact in complex networks rather than a one-way deterministic process.
We dive deep into Dr. Noble's argument that biology needs to move beyond reductionist views, emphasizing that life is more than just the sum of its genetic code. He explains how AI struggles to replicate even simple biological systems, and how biology’s complexity suggests that life’s logic lies not in DNA alone but in the entire organism.
The conversation covers his thoughts on the flaws of Neo-Darwinism, the influence of environmental factors on evolution, and the future of biology as a field that recognizes the interaction between nature and nurture. We also explore the implications of his work for health and longevity, and how common perspectives on genetics might need rethinking.
All the topics we covered in the episode:
-The critique of Neo-Darwinism and the future of evolutionary theory.
-Systems biology: Understanding life beyond the gene.
-The complexity of biology: Why reductionism falls short.
-Evolution and inheritance: The role of environment in shaping species.
-Health implications of Dr. Noble’s work: Longevity, lifestyle, and the limits of genome-based predictions.
Join us for a thrilling discussion on the future of biology, evolution, and the practical implications for health and science.
Follow our host, Waheed Rahman (@iwaheedo), for more updates on tech, civilizational growth, progress studies, and emerging markets.
Timestamps:
(00:00) - Intro
(03:04) - Why Was The Last 80 Years of Biology Wrong?
(08:17) - Where does Logic come from?
(13:03) - Is Evolution Truly Random or Driven by Purpose?
(22:05) - Is Nurture more important than Nature?
(29:06) - Denis Noble calls for a rewrite of all Biology textbooks
(32:48) - Is Neo-Darwinism Just a Model? Understanding the Difference Between Evolution and the Creationism Debate
(39:22) - Natural Selection vs. Lamarckian Evolution: How Darwin Changed Our Understanding of Survival Traits
(46:03) - Reductionism vs. Integrationism in Science: How the 'Third Way' Challenges Neo-Darwinism
(49:43) - What Does Epigenetics Mean for the Average Person? How Denis Noble's Paradigm Shift Impacts Everyday Health and Life?
(69:29) - Is Western Science Facing a Paradigm Shift? Rethinking How We Determine Truth and Health in Light of Eastern and Western Influences
(75:21) - Why Reductionism Dominates Science: The Political and Practical Challenges of Embracing a Systems Biology Approach
(82:49) - Can We Trust AI to Behave Ethically? The Need to Connect Philosophy with Technology in AI Development
(86:46) - Outro
More from The Innovation Civilization Podcast
We spend a lot of time asking what AI can do. Write software. Analyse a company. Design an experiment. A harder question follows: if those capabilities become widely available, where does value move? That was the starting point for our conversation with Omri Amirav-Drory, a scientist, founder, and general partner who leads NFX Bio. Before becoming an investor, he founded Genome Compiler, which was acquired by Twist Bioscience. We connected through his essay, The Case for Venture Capital in the Age of Superintelligence. It asks what investors should fund when AI might eventually outperform the companies—and investors—they back. nfx.com Omri is refreshingly willing to include himself in that question. “Everybody has their own excuse why their job is special.” His answer takes us through robotics, biology, longevity, and the future of work. The thread connecting them is simple: as one capability becomes abundant, the opportunity moves towards whatever still constrains progress. Three ideas to take into the episode: Faster intelligence still has to work through the physical world. Biology could become a much larger frontier for company building. Abundance changes what is valuable—and what gives people meaning.
We're joined by Professor Jacopo Buongiorno, Professor of Nuclear Science and Engineering at MIT, Director of the Center for Advanced Nuclear Energy Systems, and Director of Science and Technology at the MIT Nuclear Reactor Laboratory. His research spans reactor safety, advanced nuclear systems, small modular reactors, microreactors, and the future of nuclear energy in a carbon-constrained world. Jacopo’s central argument is clear and balanced: nuclear is not the answer to every energy problem, but it is very likely part of any serious solution. It is low-carbon, extremely reliable, incredibly energy dense, and physically compact. But the challenge is no longer whether nuclear works. The challenge is whether the West still remembers how to build it — on time, on budget, and at scale.
We're joined by David E. Spiro, political scientist and author of The Hidden Hand of American Hegemony: Petrodollar Recycling and International Markets.
We're joined by Ian Morris, British historian, archaeologist, and author of Foragers, Farmers, and Fossil Fuels
We’re joined by Professor Tim Minshall, a leading authority on innovation and industrial strategy, and one of the most influential voices shaping how ideas move from labs into the real economy.